Armstrong D, Aslani S, Nafie J, Wu Y, Stoddart J
JACS Au. 2025; 5(2):693-701.
PMID: 40017754
PMC: 11863152.
DOI: 10.1021/jacsau.4c00962.
Szakaly P, Papp D, Steckel A, Varga E, Schlosser G
J Am Soc Mass Spectrom. 2025; 36(2):258-264.
PMID: 39855639
PMC: 11808773.
DOI: 10.1021/jasms.4c00243.
Hewitt C, Wixon N, Gallegos A, Zhou Y, Huber V, Killian M
Vaccines (Basel). 2025; 13(1.
PMID: 39852858
PMC: 11769224.
DOI: 10.3390/vaccines13010079.
Man D, Nitu E, Temereanca C, Sbarcea L, Ledeti A, Ivan D
Pharmaceutics. 2025; 16(12.
PMID: 39771536
PMC: 11677897.
DOI: 10.3390/pharmaceutics16121557.
Brettner F, Gier S, Haessler A, Schreiner J, Vogel-Kindgen S, Windbergs M
Discov Nano. 2024; 19(1):211.
PMID: 39707045
PMC: 11662127.
DOI: 10.1186/s11671-024-04175-6.
How Do Cyclodextrins and Dextrans Affect the Gut Microbiome? Review of Prebiotic Activity.
Gosciniak A, Laine E, Cielecka-Piontek J
Molecules. 2024; 29(22).
PMID: 39598705
PMC: 11596334.
DOI: 10.3390/molecules29225316.
Antiseptics: An expeditious third force in the prevention and management of coronavirus diseases.
Okeke K, Ahamefule C, Nnabuife O, Orabueze I, Iroegbu C, Egbe K
Curr Res Microb Sci. 2024; 7:100293.
PMID: 39497935
PMC: 11532748.
DOI: 10.1016/j.crmicr.2024.100293.
Host-Guest Interaction Study of Olmesartan Medoxomil with β-Cyclodextrin Derivatives.
Andor M, Temereanca C, Sbarcea L, Ledeti A, Man D, Mornos C
Molecules. 2024; 29(10).
PMID: 38792072
PMC: 11123892.
DOI: 10.3390/molecules29102209.
Incorporation of Resveratrol-Hydroxypropyl-β-Cyclodextrin Complexes into Hydrogel Formulation for Wound Treatment.
Radeva L, Yordanov Y, Spassova I, Kovacheva D, Tibi I, Zaharieva M
Gels. 2024; 10(5).
PMID: 38786263
PMC: 11121020.
DOI: 10.3390/gels10050346.
Development of a scalable recombinant system for cyclic beta-1,2-glucans production.
Guidolin L, Caillava A, Landoni M, Couto A, Comerci D, Ciocchini A
Microb Cell Fact. 2024; 23(1):130.
PMID: 38711033
PMC: 11071196.
DOI: 10.1186/s12934-024-02407-z.
Investigation on the Combined Effect of Hydroxypropyl Beta-Cyclodextrin (HPβCD) and Polysorbate in Monoclonal Antibody Formulation.
Huang J, Hong S, Goh L, Zhang H, Peng T, Chow K
Pharmaceuticals (Basel). 2024; 17(4).
PMID: 38675488
PMC: 11054243.
DOI: 10.3390/ph17040528.
Transport Properties in Multicomponent Systems Containing Cyclodextrins and Nickel Ions.
Fangaia S, Silva D, Messias A, Nicolau P, Valente A, Rodrigo M
Int J Mol Sci. 2024; 25(8).
PMID: 38673912
PMC: 11050376.
DOI: 10.3390/ijms25084328.
Antimicrobial Activities of Essential Oils Nanoencapsulated into Hydroxypropyl-beta-cyclodextrins.
Alabrahim O, Azzazy H
ACS Omega. 2024; 9(11):12622-12634.
PMID: 38524461
PMC: 10955754.
DOI: 10.1021/acsomega.3c07413.
Enhanced Tumor Targeting and Antitumor Activity of Methylated β-Cyclodextrin-Threaded Polyrotaxanes by Conjugating Cyclic RGD Peptides.
Zhang S, Tamura A, Yui N
Biomolecules. 2024; 14(2).
PMID: 38397461
PMC: 10886891.
DOI: 10.3390/biom14020223.
Improved antimicrobial activities of essential oils nanoencapsulated into hydroxypropyl-beta-cyclodextrins.
Alabrahim O, Alwahibi S, Azzazy H
Nanoscale Adv. 2024; 6(3):910-924.
PMID: 38298595
PMC: 10825941.
DOI: 10.1039/d3na00882g.
Free Radical Inhibition Using a Water-Soluble Curcumin Complex, NDS27: Mechanism Study Using EPR, Chemiluminescence, and Docking.
Mouithys-Mickalad A, Etse K, Franck T, Ceusters J, Niesten A, Graide H
Antioxidants (Basel). 2024; 13(1).
PMID: 38247504
PMC: 10812671.
DOI: 10.3390/antiox13010080.
Lidocaine-Liposomes-A Promising Frontier for Transdermal Pain Management.
Leon M, Mastaleru A, Oancea A, Alexa-Stratulat T, Peptu C, Tamba B
J Clin Med. 2024; 13(1).
PMID: 38202278
PMC: 10779996.
DOI: 10.3390/jcm13010271.
Conversion of raltegravir carrying a 1,3,4-oxadiazole ring to a hydrolysis product upon pH changes decreases its antiviral activity.
Nakamura T, Okumura M, Takamune N, Hirotsu T, Sugiura M, Yasunaga J
PNAS Nexus. 2024; 3(1):pgad446.
PMID: 38170115
PMC: 10758923.
DOI: 10.1093/pnasnexus/pgad446.
Neurosteroids as Novel Anticonvulsants for Refractory Status Epilepticus and Medical Countermeasures for Nerve Agents: A 15-Year Journey to Bring Ganaxolone from Bench to Clinic.
Reddy D
J Pharmacol Exp Ther. 2023; 388(2):273-300.
PMID: 37977814
PMC: 10801762.
DOI: 10.1124/jpet.123.001816.
Cyclodextrins for the Delivery of Bioactive Compounds from Natural Sources: Medicinal, Food and Cosmetics Applications.
Christaki S, Spanidi E, Panagiotidou E, Athanasopoulou S, Kyriakoudi A, Mourtzinos I
Pharmaceuticals (Basel). 2023; 16(9).
PMID: 37765082
PMC: 10535610.
DOI: 10.3390/ph16091274.